For years, the American Association of Oral and Maxillofacial Surgeons (AAOMS) has been crafting strategies to tackle medication-related osteonecrosis of the jaws (MRONJ), formerly known as bisphosphonate-related osteonecrosis of the jaws. In an update published in the March 2024 issue of the Journal of Oral and Maxillofacial Surgery, experts from AAOMS explain revised diagnosis and management protocols, medication comparisons, and preventive measures aimed at empowering health care providers and enhancing patient care.
Aiya Almogaber, PharmD